News + Seminars | N=1 Collaborative

top of page

Search

Workshops & Presentations

Bold Predictions for Human Genomics by 2030: Session 10

Suppression of mutant C9orf72 expression by a potent mixed backbone antisense oligonucleotide

Workshops & Presentations

Year End Review and Outcome Measures Workshop

Regulatory Guidances

CMC Recommendations Draft Guidance

Investigational New Drug Application Submissions for Individualized Antisense Oligonucleotide Drug Products for Severely Debilitating...

Workshops & Presentations

Institutional Implementation Workshop

Workshops & Presentations

N=1 Collaborative Introduction & Patient Selection Workshop

Illustrated Examples

Nonclinical Testing Draft Guidance

Nonclinical Testing of Individualized Antisense Oligonucleotide Drug Products for Severely Debilitating or Life-Threatening Diseases...

Regulatory Guidances

Administrative and Procedural Draft Guidance

IND Submissions for Individualized Antisense Oligonucleotide Drug Products: Administrative and Procedural Recommendations Guidance for...

bottom of page